NEO
NEO
NASDAQ · Health Care

Neogenomics Inc

$15.16
+0.19 (+1.27%)
As of Jul 4, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
739.32M
Net Income
-109,807,589
Gross Margin
43.2%
Profit Margin
-14.9%
Rev Growth
+12.6%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 739.32M 656.70M 759.46M 804.45M
Gross Profit 319.46M 283.76M 380.80M 403.36M
Operating Income -117,773,104 -94,151,531 67.00M 69.80M
Net Income -109,807,589 -87,783,647 56.53M 50.19M
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Rev Growth +12.6% +12.6% -7.8% -8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 286.31M 286.31M 99.64M 90.17M
Total Equity 700.70M 700.70M 945.36M 961.54M
D/E Ratio 0.41 0.41 0.11 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -81,473,507 -68,750,960 95.37M 98.54M
Free Cash Flow 21.30M 34.74M